Illumina introduces next generation cancer research assay, TruSight Oncology 500: San Diego Friday, August 1, 2025, 12:00 Hrs [IST] Illumina Inc., a biotechnology company develops ...

Over 100 prominent companies are currently engaged in developing treatments for osteoarthritis. Among them, Biosplice Therapeutics has drug candidates that have reached the most advanced stage—Phase ...

You might be familiar with the terms "seggs" and "unalive" if you've spent time on social media platforms. They're a part of ...

Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its flagship cancer research assay that enables comprehensive genomic profiling. Comprehensive ...

If you rotate an image of a molecular structure, a human can tell the rotated image is still the same molecule, but a machine ...

Ink authentication is often complicated by tampering, aging, and chemical variability. Now, forensic scientists are turning ...

Associate Professor Mark Barrow of the Department of Chemistry at the University of Warwick presented an engaging account of ...

Aladdin by Blackrock (NYSE: BLK) uses AI to crunch massive datasets, including stock prices, earnings, macroeconomic data, ...

Customized pricing – where each customer receives a different price for the same product – is a holy grail for businesses ...

In Ex parte Michalek, the PTAB evaluated an invention involving medical health technology and artificial intelligence. While ...